A Phase II Trial of Bendamustine, Carboplatin and Dexamethasone (BCD) for Refractory or Relapsed Peripheral T-Cell Lymphoma (BENCART): A Consortium for Improving Survival of Lymphoma (CISL) Trial

被引：0

作者：

Park, Byeong-Bae ^{[1
]}

Kim, Won Seog ^{[2
]}

Suh, Cheolwon ^{[3
]}

Yoon, Dok Hyun ^{[3
]}

Won, Jong-Ho ^{[4
]}

Yang, Deok-Hwan ^{[5
]}

Do, Young-Rok ^{[6
]}

Lee, Won Sik ^{[7
]}

Kim, Jeong-A ^{[8
]}

Kim, Min Kyoung ^{[9
]}

Jo, Jae-Cheol ^{[10
]}

Koh, Youngil ^{[11
]}

机构：

[1] Hanyang Univ, Coll Med, Seoul, South Korea

[2] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea

[3] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea

[4] Soonchunhyang Univ, Coll Med, Seoul, South Korea

[5] Chonnam Natl Univ Hwasun Hosp, Dept Hematol Oncol, Hwasun, South Korea

[6] Dongsan Med Ctr, Daegu, South Korea

[7] Inje Univ, Coll Med, Busan, South Korea

[8] Catholic Univ Korea, St Vincents Hosp, Suwon, South Korea

[9] Yeungnam Univ Med Ctr, Daegu, South Korea

[10] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Ulsan, South Korea

[11] Seoul Natl Univ Hosp, Seoul, South Korea

来源：

关键词：

D O I：

10.1182/blood.V128.22.1823.1823

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1823

引用

页数：5